| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | EVP Of R&D | EVP Of R&D And CMO +2 more
3 companies
Amado Rafael is an EVP Of R&D at Allogene Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | ZLAB Zai Lab Ltd | See Remarks | Sale+OE | 19,363 | $26.30 | $509,169.45 | -46.1% | -35.8% | -4.8% | |
| Aug 2, 2022 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 2,000 | $11.97 | $23,940.00 | -0.4% | -17.7% | -62.5% | |
| Jul 5, 2022 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 2,000 | $11.44 | $22,880.00 | -0.4% | -9.3% | -57.7% | |
| Jun 21, 2022 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 2,000 | $11.18 | $22,360.00 | -0.4% | +15.7% | -58.6% | |
| May 19, 2022 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 11,500 | $7.40 | $85,091.95 | -2.1% | +109.4% | -19.5% | |
| Mar 15, 2022 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 5,169 | $7.71 | $39,847.82 | -1.6% | +13.5% | -27.4% | |
| Oct 1, 2021 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 11,507 | $24.35 | $280,185.09 | -3.4% | -37.3% | -56.0% | |
| Mar 15, 2021 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 2,798 | $38.05 | $106,470.62 | -2.5% | -35.0% | -80.0% | |
| Oct 7, 2020 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 16,538 | $39.40 | $651,514.51 | -12.9% | - | - | |
| Oct 1, 2020 | ALLO Allogene Therapeutics, Inc. | EVP Of R&D And CMO | Sell | 9,752 | $36.37 | $354,661.71 | -7.1% | - | - |